ANIDULAFUNGIN Accord subst sèche 100 mg flac
7680683570019
CH-68357
J02AX06
08.06.0.
Reimbursement limitations:
ECALTA2
Traitement des candidémies et des formes invasives de la candidose chez les patients adultes récemment …
1 / 3
google
Details
- Product number
- 6835701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: anidulafunginum 100 mg, fructosum 100 mg, mannitolum, polysorbatum 80, acidum (S)-lacticum, acidum hydrochloridum, natrii hydroxidum corresp. natrium max. 1.5 mg, pro vitro.
Articles (1)
Anidulafungin Accord 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
100.0 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 381.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2022
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68357
- Drug name
- Anidulafungin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J02AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 18/11/2021
- Authorization expiration date
- 17/11/2026
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANIDULAFUNGIN Accord subst sèche 100 mg flac
- Description (DE)
- ANIDULAFUNGIN Accord Trockensub 100 mg Durchstf
- Market launch
- 18/11/2021
- Narcotic (BTM)
- No